Edition:
India

Pain Therapeutics Inc (PTIE.OQ)

PTIE.OQ on NASDAQ Stock Exchange Global Select Market

7.79USD
19 Jan 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.79
Open
$7.71
Day's High
$8.14
Day's Low
$7.71
Volume
34,576
Avg. Vol
159,241
52-wk High
$12.80
52-wk Low
$3.10

Select another date:

Tue, Jan 9 2018

BRIEF-Pain Therapeutics Reports Positive Results From Nasal Abuse Potential Study With Remoxy

* PAIN THERAPEUTICS REPORTS POSITIVE TOP-LINE RESULTS FROM NASAL ABUSE POTENTIAL STUDY WITH REMOXY™

BRIEF-Pain Therapeutics Reports Positive Regulatory Meeting For Remoxy

* PAIN THERAPEUTICS REPORTS POSITIVE REGULATORY MEETING FOR REMOXY™

BRIEF-Pain therapeutics reports Q3 loss per share $0.40

* Pain therapeutics reports third quarter 2017 financial results

BRIEF-Pain Therapeutics announces upcoming meeting with FDA

* Pain Therapeutics - ‍U.S. FDA agreed to pre-nda guidance meeting to discuss co's NDA resubmission for remoxy er as a treatment for severe chronic pain​

BRIEF-Pain Therapeutics announces successful Phase I clinical study for PTI-125

* Pain Therapeutics announces successful Phase I clinical study for PTI-125

BRIEF-National Institute on Drug Abuse awards Pain Therapeutics $2.2 mln grant

* National Institute on Drug Abuse awards Pain Therapeutics $2.2 million grant Source text for Eikon: Further company coverage:

BRIEF-Pain Therapeutics reports Q2 loss per share $0.64

* Pain Therapeutics reports Q2 2017 financial results and mid-year corporate update

BRIEF-Pain Therapeutics announces FDA clears investigational new drug application for PTI-125

* Pain Therapeutics announces FDA has cleared an investigational new drug (IND) application for PTI-125

Select another date: